These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 11444429

  • 1. Dopamine D2 receptor gene expression in human adenohypophysial adenomas.
    Stefaneanu L, Kovacs K, Horvath E, Buchfelder M, Fahlbusch R, Lancranjan L.
    Endocrine; 2001 Apr; 14(3):329-36. PubMed ID: 11444429
    [Abstract] [Full Text] [Related]

  • 2. Growth hormone (GH) and prolactin (PRL) gene expression and immunoreactivity in GH- and PRL-producing human pituitary adenomas.
    Li J, Stefaneanu L, Kovacs K, Horvath E, Smyth HS.
    Virchows Arch A Pathol Anat Histopathol; 1993 Apr; 422(3):193-201. PubMed ID: 8493775
    [Abstract] [Full Text] [Related]

  • 3. In situ hybridization study of estrogen receptor messenger ribonucleic acid in human adenohypophysial cells and pituitary adenomas.
    Stefaneanu L, Kovacs K, Horvath E, Lloyd RV, Buchfelder M, Fahlbusch R, Smyth H.
    J Clin Endocrinol Metab; 1994 Jan; 78(1):83-8. PubMed ID: 8288720
    [Abstract] [Full Text] [Related]

  • 4. Expression of von Hippel-Lindau protein (VHL-P) in nontumorous and adenomatous human pituitaries.
    Vidal S, Stefaneanu L, Kovacs K, Scheithauer BW.
    Pituitary; 1999 May; 1(3-4):227-32. PubMed ID: 11081202
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Heterogeneous dopamine D2 receptor subtype messenger ribonucleic acid expression in clinically nonfunctioning pituitary adenomas.
    Renner U, Arzberger T, Pagotto U, Leimgruber S, Uhl E, Müller A, Lange M, Weindl A, Stalla GK.
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1368-75. PubMed ID: 9543168
    [Abstract] [Full Text] [Related]

  • 7. Dopamine 2 receptor expression in various pathological types of clinically non-functioning pituitary adenomas.
    Gabalec F, Beranek M, Netuka D, Masopust V, Nahlovsky J, Cesak T, Marek J, Cap J.
    Pituitary; 2012 Jun; 15(2):222-6. PubMed ID: 21597974
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Rab3B immunoexpression in human pituitary adenomas.
    Rotondo F, Scheithauer BW, Kovacs K, Bell DC.
    Appl Immunohistochem Mol Morphol; 2009 May; 17(3):185-8. PubMed ID: 19384079
    [Abstract] [Full Text] [Related]

  • 10. Differential expression of somatostatin and dopamine receptor subtype genes in adrenocorticotropin (ACTH)-secreting pituitary tumors and silent corticotroph adenomas.
    Tateno T, Kato M, Tani Y, Oyama K, Yamada S, Hirata Y.
    Endocr J; 2009 May; 56(4):579-84. PubMed ID: 19318729
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotroph.
    Asa SL, Bamberger AM, Cao B, Wong M, Parker KL, Ezzat S.
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2165-70. PubMed ID: 8964846
    [Abstract] [Full Text] [Related]

  • 13. Expression of functional growth hormone secretagogue receptors in human pituitary adenomas: polymerase chain reaction, triple in-situ hybridization and cell culture studies.
    Barlier A, Zamora AJ, Grino M, Gunz G, Pellegrini-Bouiller I, Morange-Ramos I, Figarella-Branger D, Dufour H, Jaquet P, Enjalbert A.
    J Neuroendocrinol; 1999 Jul; 11(7):491-502. PubMed ID: 10444306
    [Abstract] [Full Text] [Related]

  • 14. Dopamine 2 and somatostatin 1-5 receptors coexpression in clinically non-functioning pituitary adenomas.
    Gabalec F, Drastikova M, Cesak T, Netuka D, Masopust V, Machac J, Marek J, Cap J, Beranek M.
    Physiol Res; 2015 Jul; 64(3):369-77. PubMed ID: 25536318
    [Abstract] [Full Text] [Related]

  • 15. Molecular Biology of Pituitary Adenomas.
    Faltermeier CM, Magill ST, Blevins LS, Aghi MK.
    Neurosurg Clin N Am; 2019 Oct; 30(4):391-400. PubMed ID: 31471046
    [Abstract] [Full Text] [Related]

  • 16. Molecular cytogenetics of chromosome 11 in pituitary adenomas: a comparison of fluorescence in situ hybridization and DNA ploidy study.
    Kontogeorgos G, Kapranos N, Orphanidis G, Rologis D, Kokka E.
    Hum Pathol; 1999 Nov; 30(11):1377-82. PubMed ID: 10571521
    [Abstract] [Full Text] [Related]

  • 17. Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice.
    Asa SL, Kelly MA, Grandy DK, Low MJ.
    Endocrinology; 1999 Nov; 140(11):5348-55. PubMed ID: 10537166
    [Abstract] [Full Text] [Related]

  • 18. Expression profiles of somatostatin, dopamine, and estrogen receptors in pituitary adenomas determined by means of synthetic multilocus calibrators.
    Drastikova M, Beranek M, Gabalec F, Netuka D, Masopust V, Cesak T, Marek J, Palicka V, Cap J.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Jun; 160(2):238-43. PubMed ID: 26607296
    [Abstract] [Full Text] [Related]

  • 19. Expression of dopamine 2 receptor subtype mRNA in clinically nonfunctioning pituitary adenomas.
    Su Z, Wang C, Wu J, Jiang X, Chen Y, Chen Y, Zheng W, Zhuge Q, Wu Z, Zeng Y.
    Neurol Sci; 2012 Apr; 33(2):275-9. PubMed ID: 21748460
    [Abstract] [Full Text] [Related]

  • 20. Localization of insulin-like growth factor-II mRNA in human pituitary adenomas.
    Yokoyama S, Thapar K, Kovacs K, Stefaneanu L.
    Virchows Arch; 1998 Mar; 432(3):241-6. PubMed ID: 9532003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.